Active Ingredient: DABIGATRAN ETEXILATE MESYLATE
Proprietary Name: DABIGATRAN ETEXILATE MESYLATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213879
Product Number: 001
Approval Date: May 22, 2024
Applicant Holder Full Name: MSN LABORATORIES PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: DABIGATRAN ETEXILATE MESYLATE
Proprietary Name: DABIGATRAN ETEXILATE MESYLATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213879
Product Number: 002
Approval Date: May 22, 2024
Applicant Holder Full Name: MSN LABORATORIES PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information